Prostatic-Like Syndrome in a Woman with Chronic Lymphocytic Leukemia: Sequential Kinase Inhibitor Therapy

Chronic lymphocytic leukemia (CLL) is an incurable lymphoproliferative disorder with a heterogeneous genetic and clinical course. Two kinase inhibitors, ibrutinib and idelalisib, have demonstrated achievement of complete and durable remissions in relapse/refractory genetically unselected CLL patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Velasco-Rodríguez, Diego, Piris-Villaespesa, Miguel, Soteras, Carmen, Vallés, Ana, García-Marco, José Antonio, García-Vela, José Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511649/
https://www.ncbi.nlm.nih.gov/pubmed/28751992
http://dx.doi.org/10.1155/2017/3869020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511649/
https://www.ncbi.nlm.nih.gov/pubmed/28751992
http://dx.doi.org/10.1155/2017/3869020

Ejemplares similares